A history of traumatic brain injury was linked to long-term cognitive decline involving speech functions, specifically where ...

Oral upadacitinib may be a promising treatment option for patients with atopic dermatitis-type chronic hand eczema that is ...

In this video, Philip J. Mease, MD, discusses the potential for the development of a T-cell engaging antibody.

In this video, Philip J. Mease, MD, discusses results from the phase 2 ARGO clinical trials of sonelokimab for psoriatic arthritis, presented at the EULAR 2025 Congress.

In this video, Philip J. Mease, MD, discusses results from phase 3 clinical trials of deucravacitinib for psoriatic arthritis, presented at the EULAR 2025 Congress.

In this video, Philip J. Mease, MD, director of rheumatology research at Providence Swedish Medical Center, in Seattle, discusses results from phase 3b clinical trials of guselkumab.The data, ...